why choose us

First received: May 24, 2023

Clinical Trial: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Neuromyelitis Optica Spectrum Disorder

Study Type: OBSERVATIONAL


Official Title: Effectiveness and Safety of Inebilizumab in the Acute Phase of Neuromyelitis Optica Spectrum Disorders-a Multicentric, Prospective, Real Word Study

Brief Summary: This study is aimed to observe the effectiveness and safety of inebilizumab in the acute phase of neuromyelitis optica spectrum disorders.

Read more